Part of the Biochemistry, Biophysics, and Structural Biology Commons
2008
Abundant anti-apoptotic BCL-2 is a molecular target in leukaemias with t(4;11) translocation, Blaine W. Robinson, Kathryn C. Behling, Manish Gupta, Alena Y. Zhang, Jonni S. Moore, Andrew D. Bantly, Cheryl L. Willman, Andrew J. Carroll, Peter C. Adamson, Jeffrey S. Barrett, Carolyn A. Felix
Kathryn Behling
2005
Pan-BCL-2 Family Small Molecule Inhibitor GX015-070 (GeminX, Inc.) Exhibits Single Agent Cytotoxicity, Is Synergistic with Select Anti-Leukemia Cytotoxic Agents, and Induces Apoptosis in Cell Lines with t(4;11)(q21;q23) Translocations., Jessicca M. Rege, Blaine W. Robinson, Manish Gupta, Jeffrey S. Barrett, Peter C. Adamson, Kathryn C. Behling, Andrew D. Bantly, Jonni S. Moore, Carolyn A. Felix
Kathryn Behling
